AAPL344.58-4.33 (-1.24%) ▼|ABBV295.89+5.10 (+1.75%) ▲|ABT105.88+1.31 (+1.25%) ▲|ACN258.78+11.56 (+4.68%) ▲|ADBE249.86+1.74 (+0.70%) ▲|AMAT385.99-35.67 (-8.46%) ▼|AMD498.33-68.09 (-12.02%) ▼|AMGN469.17+8.44 (+1.83%) ▲|AMT189.49+3.61 (+1.94%) ▲|AMZN238.81-4.98 (-2.04%) ▼|AVGO321.30-23.71 (-6.87%) ▼|AXP317.93-5.78 (-1.79%) ▼|BA170.69-1.97 (-1.14%) ▼|BAC49.87-1.27 (-2.48%) ▼|BKNG148.25-2.18 (-1.45%) ▼|BLK1,141.53-34.72 (-2.95%) ▼|BMY62.92+1.53 (+2.49%) ▲|BNY146.22-3.16 (-2.11%) ▼|BRK-B544.05+2.09 (+0.39%) ▲|C121.41-4.35 (-3.46%) ▼|CAT625.45-21.95 (-3.39%) ▼|CL96.22+3.06 (+3.28%) ▲|CMCSA23.00+0.73 (+3.26%) ▲|COF203.20-5.54 (-2.65%) ▼|COP152.88+2.85 (+1.90%) ▲|COST1,019.47+24.86 (+2.50%) ▲|CRM229.37-1.53 (-0.66%) ▼|CSCO104.34-4.25 (-3.91%) ▼|CVS90.70+0.37 (+0.41%) ▲|CVX234.85+3.39 (+1.46%) ▲|DE670.08+10.08 (+1.53%) ▲|DHR231.11-5.88 (-2.48%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK128.04+2.14 (+1.70%) ▲|EMR164.52-6.22 (-3.64%) ▼|FDX317.08+9.26 (+3.01%) ▲|GD374.12+3.30 (+0.89%) ▲|GE301.36-11.69 (-3.73%) ▼|GEV851.88-35.97 (-4.05%) ▼|GILD172.37+6.76 (+4.08%) ▲|GM87.50+1.78 (+2.08%) ▲|GOOG275.98-6.34 (-2.25%) ▼|GOOGL277.81-6.02 (-2.12%) ▼|GS881.92-45.81 (-4.94%) ▼|HD329.52+0.54 (+0.16%) ▲|HON220.40-1.75 (-0.79%) ▼|IBM256.03-2.26 (-0.87%) ▼|INTC63.65-28.43 (-30.87%) ▼|INTU340.74+9.55 (+2.88%) ▲|ISRG434.98-13.78 (-3.07%) ▼|JNJ275.74+0.54 (+0.20%) ▲|JPM336.11-7.47 (-2.17%) ▼|KO94.50+1.68 (+1.80%) ▲|LIN515.52+12.37 (+2.46%) ▲|LLY1,424.35+50.65 (+3.69%) ▲|LMT638.96-4.63 (-0.72%) ▼|LOW209.47+2.19 (+1.05%) ▲|LRCX233.44-20.96 (-8.24%) ▼|MA638.75+3.05 (+0.48%) ▲|MCD259.12+1.74 (+0.67%) ▲|MDLZ65.10+2.57 (+4.11%) ▲|MDT96.62-0.50 (-0.51%) ▼|META614.98-9.54 (-1.53%) ▼|MMM174.24-3.12 (-1.76%) ▼|MO78.51+1.76 (+2.29%) ▲|MRK150.17+3.84 (+2.62%) ▲|MS182.31-6.54 (-3.46%) ▼|MSFT520.78-9.36 (-1.77%) ▼|MU865.78-68.50 (-7.33%) ▼|NEE84.25+2.11 (+2.57%) ▲|NFLX61.94-0.12 (-0.19%) ▼|NKE38.83+0.41 (+1.05%) ▲|NOW103.76-5.91 (-5.39%) ▼|NVDA202.22-11.44 (-5.35%) ▼|ORCL130.08-9.48 (-6.79%) ▼|PEP138.28+4.49 (+3.36%) ▲|PFE30.55+0.60 (+2.01%) ▲|PG162.82+2.23 (+1.39%) ▲|PLTR184.51-11.91 (-6.06%) ▼|PM209.11+0.61 (+0.29%) ▲|QCOM162.40-23.02 (-12.41%) ▼|RTX201.04+1.64 (+0.82%) ▲|SBUX103.90-1.61 (-1.53%) ▼|SCHW87.74-1.73 (-1.93%) ▼|SO94.10+1.11 (+1.19%) ▲|SPG218.08+2.36 (+1.09%) ▲|T21.45+0.53 (+2.51%) ▲|TMO692.69-16.49 (-2.33%) ▼|TMUS158.02+10.73 (+7.28%) ▲|TSLA394.93-8.37 (-2.08%) ▼|TXN295.63-15.79 (-5.07%) ▼|UBER65.01-0.73 (-1.11%) ▼|UNH408.73-2.18 (-0.53%) ▼|UNP302.84+0.91 (+0.30%) ▲|UPS108.28+0.95 (+0.89%) ▲|USB59.30-1.34 (-2.21%) ▼|V415.56+5.02 (+1.22%) ▲|VZ45.07+1.41 (+3.22%) ▲|WFC83.17-1.64 (-1.93%) ▼|WMT124.02+2.77 (+2.28%) ▲|XOM185.94+2.65 (+1.45%) ▲|AAPL344.58-4.33 (-1.24%) ▼|ABBV295.89+5.10 (+1.75%) ▲|ABT105.88+1.31 (+1.25%) ▲|ACN258.78+11.56 (+4.68%) ▲|ADBE249.86+1.74 (+0.70%) ▲|AMAT385.99-35.67 (-8.46%) ▼|AMD498.33-68.09 (-12.02%) ▼|AMGN469.17+8.44 (+1.83%) ▲|AMT189.49+3.61 (+1.94%) ▲|AMZN238.81-4.98 (-2.04%) ▼|AVGO321.30-23.71 (-6.87%) ▼|AXP317.93-5.78 (-1.79%) ▼|BA170.69-1.97 (-1.14%) ▼|BAC49.87-1.27 (-2.48%) ▼|BKNG148.25-2.18 (-1.45%) ▼|BLK1,141.53-34.72 (-2.95%) ▼|BMY62.92+1.53 (+2.49%) ▲|BNY146.22-3.16 (-2.11%) ▼|BRK-B544.05+2.09 (+0.39%) ▲|C121.41-4.35 (-3.46%) ▼|CAT625.45-21.95 (-3.39%) ▼|CL96.22+3.06 (+3.28%) ▲|CMCSA23.00+0.73 (+3.26%) ▲|COF203.20-5.54 (-2.65%) ▼|COP152.88+2.85 (+1.90%) ▲|COST1,019.47+24.86 (+2.50%) ▲|CRM229.37-1.53 (-0.66%) ▼|CSCO104.34-4.25 (-3.91%) ▼|CVS90.70+0.37 (+0.41%) ▲|CVX234.85+3.39 (+1.46%) ▲|DE670.08+10.08 (+1.53%) ▲|DHR231.11-5.88 (-2.48%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK128.04+2.14 (+1.70%) ▲|EMR164.52-6.22 (-3.64%) ▼|FDX317.08+9.26 (+3.01%) ▲|GD374.12+3.30 (+0.89%) ▲|GE301.36-11.69 (-3.73%) ▼|GEV851.88-35.97 (-4.05%) ▼|GILD172.37+6.76 (+4.08%) ▲|GM87.50+1.78 (+2.08%) ▲|GOOG275.98-6.34 (-2.25%) ▼|GOOGL277.81-6.02 (-2.12%) ▼|GS881.92-45.81 (-4.94%) ▼|HD329.52+0.54 (+0.16%) ▲|HON220.40-1.75 (-0.79%) ▼|IBM256.03-2.26 (-0.87%) ▼|INTC63.65-28.43 (-30.87%) ▼|INTU340.74+9.55 (+2.88%) ▲|ISRG434.98-13.78 (-3.07%) ▼|JNJ275.74+0.54 (+0.20%) ▲|JPM336.11-7.47 (-2.17%) ▼|KO94.50+1.68 (+1.80%) ▲|LIN515.52+12.37 (+2.46%) ▲|LLY1,424.35+50.65 (+3.69%) ▲|LMT638.96-4.63 (-0.72%) ▼|LOW209.47+2.19 (+1.05%) ▲|LRCX233.44-20.96 (-8.24%) ▼|MA638.75+3.05 (+0.48%) ▲|MCD259.12+1.74 (+0.67%) ▲|MDLZ65.10+2.57 (+4.11%) ▲|MDT96.62-0.50 (-0.51%) ▼|META614.98-9.54 (-1.53%) ▼|MMM174.24-3.12 (-1.76%) ▼|MO78.51+1.76 (+2.29%) ▲|MRK150.17+3.84 (+2.62%) ▲|MS182.31-6.54 (-3.46%) ▼|MSFT520.78-9.36 (-1.77%) ▼|MU865.78-68.50 (-7.33%) ▼|NEE84.25+2.11 (+2.57%) ▲|NFLX61.94-0.12 (-0.19%) ▼|NKE38.83+0.41 (+1.05%) ▲|NOW103.76-5.91 (-5.39%) ▼|NVDA202.22-11.44 (-5.35%) ▼|ORCL130.08-9.48 (-6.79%) ▼|PEP138.28+4.49 (+3.36%) ▲|PFE30.55+0.60 (+2.01%) ▲|PG162.82+2.23 (+1.39%) ▲|PLTR184.51-11.91 (-6.06%) ▼|PM209.11+0.61 (+0.29%) ▲|QCOM162.40-23.02 (-12.41%) ▼|RTX201.04+1.64 (+0.82%) ▲|SBUX103.90-1.61 (-1.53%) ▼|SCHW87.74-1.73 (-1.93%) ▼|SO94.10+1.11 (+1.19%) ▲|SPG218.08+2.36 (+1.09%) ▲|T21.45+0.53 (+2.51%) ▲|TMO692.69-16.49 (-2.33%) ▼|TMUS158.02+10.73 (+7.28%) ▲|TSLA394.93-8.37 (-2.08%) ▼|TXN295.63-15.79 (-5.07%) ▼|UBER65.01-0.73 (-1.11%) ▼|UNH408.73-2.18 (-0.53%) ▼|UNP302.84+0.91 (+0.30%) ▲|UPS108.28+0.95 (+0.89%) ▲|USB59.30-1.34 (-2.21%) ▼|V415.56+5.02 (+1.22%) ▲|VZ45.07+1.41 (+3.22%) ▲|WFC83.17-1.64 (-1.93%) ▼|WMT124.02+2.77 (+2.28%) ▲|XOM185.94+2.65 (+1.45%) ▲|
20.9 C
New York
Friday, October 30, 2026

Tag: material

Sebastopol Shows It Is The Epicenter of Global Fiber Art with the 12th International Fiber Arts Show

SEBASTOPOL, Calif., June 20, 2025 /PRNewswire/ -- Sebastopol Center for the Arts invites the public to experience the International Fiber Arts Exhibition 2025, its...

GCC Decorative Paints Industry Report 2025: $24.94 Bn Market Competition, Forecasts and Opportunities, 2020-2030F

The GCC decorative paints market is booming due to urbanization, real estate growth, and infrastructure investments. Opportunities arise in eco-friendly paints aligning with green standards and premium textures favored in luxury projects. Challenges include raw material price volatility and supply chain issues.
The GCC decorative paints market is booming due to urbanization, real estate growth, and infrastructure investments. Opportunities arise in eco-friendly paints aligning with green standards and premium textures favored in luxury projects. Challenges include raw material price volatility and supply chain issues.

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 20, 2025 /CNW/ -- Equity Insider News Commentary – Amid the wave of new...

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON, June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving...

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

BC Tech Pioneers Quality Upgrade in PV Industry

SHANGHAI, June 20, 2025 /PRNewswire/ -- During the recent 2025 SNEC exhibition in Shanghai, LONGi, a global leader in PV technology innovation, signed a strategic...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

OMS Energy Technologies Inc. Mengeluarkan Kemas Kini Operasi Pasca-IPO yang Menampilkan Pertumbuhan Pelanggan, Inisiatif Pengembangan, serta Pencapaian R&D dan Keselamatan

SINGAPURA, June 20, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” atau “Syarikat”) (Nasdaq: OMSE), sebuah pengeluar yang berorientasikan pertumbuhan bagi sistem kepala telaga permukaan (“SWS”) dan barangan tubular untuk industri minyak dan gas (“OCTG”), hari ini mengeluarkan kemas kini perniagaan yang menggariskan pencapaian terkini sambil Syarikat bersiap sedia untuk panggilan pendapatan sulungnya selepas berjaya disenaraikan di Nasdaq pada Mei 2025.

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today provided a business update outlining its recent accomplishments as the Company prepares for its inaugural earnings call following its successful Nasdaq listing in May 2025.

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to one new non-executive employee as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Company through the applicable vesting date, and the awards are subject to the terms of the Company’s 2020 Inducement Incentive Plan.

NORTHCLIFF ANNOUNCES NON-BROKERED PRIVATE PLACEMENT FINANCING

VANCOUVER, BC, June 19, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) announces that it has arranged a non-brokered private...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2025.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMaterial